english.prescrire.org > Spotlight > Archives : 2025 > PD-1 or PD-L1 immune checkpoint inhibitors: cholangitis

Spotlight: Archives

Every month, the subjects in Prescrire’s Spotlight.

2025 : 1 | 30

PD-1 or PD-L1 immune checkpoint inhibitors: cholangitis

 Adverse Effects  In 2024, a French team published an analysis of 48 reports of cholangitis attributed to a PD-1 or PD-L1 immune checkpoint inhibitor, recorded in the national pharmacovigilance database. 4 patients died, 2 from liver injury. 
Full article available for download by subscribers

 ©Prescrire 1 September 2025

Source: "PD-1 or PD-L1 immune checkpoint inhibitors: cholangitis" Prescrire Int 2025; 34 (273): 219. Subscribers only.

Filet

Enjoy full access to Prescrire International, and support independent information